Hims Hers Health Inc (HIMS)

Pretax margin

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Earnings before tax but after interest (EBT) (ttm) US$ in thousands 71,711 51,616 21,107 513 -21,571 -34,817 -46,757 -59,254 -65,731 -85,929 -86,187 -75,639 -110,795 -84,752 -71,478 -63,303 -17,987 -25,115 -19,275 -18,331
Revenue (ttm) US$ in thousands 1,476,514 1,241,994 1,067,137 959,401 872,000 792,584 710,721 616,372 526,916 444,412 373,749 320,878 271,878 228,645 195,796 171,008 148,757 132,060 90,736 54,832
Pretax margin 4.86% 4.16% 1.98% 0.05% -2.47% -4.39% -6.58% -9.61% -12.47% -19.34% -23.06% -23.57% -40.75% -37.07% -36.51% -37.02% -12.09% -19.02% -21.24% -33.43%

December 31, 2024 calculation

Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $71,711K ÷ $1,476,514K
= 4.86%

The pretax margin of Hims Hers Health Inc has shown a significant improvement over the past few years, transitioning from negative figures to positive. From March 2020 to December 2024, the pretax margin steadily improved from -33.43% to 4.86%.

The company experienced losses initially, with margins in negative double digits in 2020 and early 2021. However, there was a notable turnaround starting from March 2023, with the pretax margin gradually increasing and turning positive by the end of 2024.

This positive trend in the pretax margin indicates that the company's profitability has improved, showcasing better cost control, revenue growth, or both. Investors and stakeholders may view this upward trend favorably as it suggests a more sustainable financial performance for Hims Hers Health Inc in the future.


Peer comparison

Dec 31, 2024

Company name
Symbol
Pretax margin
Hims Hers Health Inc
HIMS
4.86%
Astrana Health Inc
ASTH
6.62%